I

Invirsa, Inc

11 employees

Invirsa develops a molecule that promotes ocular DNA repair and the innate immune response to infection and injury.

Basic info

Industry

pharmaceutical manufacturing

Sectors

BARDA
Biotechnology
Health Care
Therapeutics
ophthalmology
Pharmaceutical
pharmaceuticals
sulfur mustard

Date founded

2016

Funding rounds raised

Total raised

$7.7M

from 7 investors over 7 rounds

I

Invirsa, Inc raised $7.7M on June 14, 2023

Investors: CincyTech USA, Rev1 Ventures and JumpStart Ventures

I

Invirsa, Inc raised $1.8M on December 20, 2019

Investors: CincyTech USA

I

Invirsa, Inc raised $520K on July 28, 2017

Investors: Rev1 Ventures and CincyTech USA

I

Invirsa, Inc raised $149K on July 15, 2016

Investors: Rev1 Ventures

FAQ